T. Fujino et al., ENHANCED EXPRESSION OF HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR AND ITSRECEPTOR IN HYPERTROPHIED LEFT-VENTRICLE OF SPONTANEOUSLY HYPERTENSIVE RATS, Cardiovascular Research, 38(2), 1998, pp. 365-374
Objectives: Although heparin-binding epidermal growth factor-like grow
th factor (HB-EGF) is thought to produce hypertrophy in isolated cardi
omyocytes via an autocrine mechanism, the pathophysiological role of H
B-EGF, in myocardial hypertrophy in vivo, is not yet known. To investi
gate the involvement of HB-EGF in cardiac remodeling associated with h
ypertension in vivo, we assayed the expression of HB-EGF mRNA and prot
ein in the left ventricle (LV) during the development of left ventricu
lar hypertrophy in spontaneously hypertensive rats (SHR). Methods: Pri
or to sacrifice and assay of HB-EGF and EGF-receptor (EGF-R) mRNA, mor
phologic and hemodynamic variables were measured in SHR and in age-mat
ched Wistar Kyoto rats (WKY). At 5, 9 and 12 weeks of age, rats were k
illed, their hearts were removed, and the expression of HB-EGF and EGF
-R mRNA and protein were measured. In addition, SHR and WKY were treat
ed with enalapril, atenolol, or both for 4 weeks. Results: In untreate
d SHR, double products (i.e. systolic blood pressure (sBP) multiplied
by heart rate (IIR)), an index of mechanical load, peaked at 9 weeks.
Expression of HB-EGF mRNA was also observed to peak in these animals a
t 9 weeks, while expression of EGF-R mRNA increased from 5 to 9 weeks,
but remained constant thereafter. In untreated WKY, double products a
nd EGF-R mRNA expression did not change over time, whereas the level o
f HB-EGF message increased gradually. Antibody to HB-EGF reacted prima
rily with myocyte membranes in SHR, whereas antibody to EGF-R reacted
mainly with interstitial cells in these animals. The angiotensin-conve
rting enzyme inhibitor, enalapril, markedly decreased sBP in SHR, wher
eas the beta(1)-adrenoreceptor antagonist, atenolol, significantly dec
reased HR. While neither alone affected the expression of HB-EGF mRNA,
their combination significantly reduced the expression of HB-EGF mRNA
, as well as double products, in these rats, but had no effect on expr
ession of EGF-R mRNA. Conclusions: The enhanced expression of HB-EGF m
RNA and protein in LV of SHR suggest that this growth factor may play
an important role during the early development of LV hypertrophy and c
ardiac fibrosis in SHR. The association between double products and HB
-EGF expression suggest that the latter may be induced by increased me
chanical load and may contribute, in turn, to cardiac remodeling. (C)
1998 Elsevier Science B.V. All rights reserved.